EIZO Corporation
6737・Prime Market・Electric Appliances
Business
EIZO Corporation, founded in 1968 and headquartered in Hakusan City, Ishikawa Prefecture, is a visual equipment manufacturer forming a group of 18 companies total, comprising 6 domestic and 12 overseas subsidiaries. The company operates across five markets: B&P (Business & Plus, i.e., business and general office use), Healthcare (medical diagnostics, operating rooms, endoscopy), Creative Work (video production, printing), V&S (Vertical & Specific, i.e., air traffic control, maritime, defense, surveillance), and Amusement (LCD monitors for pachinko and pachislot machines). The company supplies products to over 100 countries worldwide, with net sales of ¥81,308 million for FY2026 (ending March 2026). Healthcare is the largest market, accounting for 45.0% of net sales, and the company claims the No.1 global market share in air traffic control applications. It also operates a systems solutions business through EIZO Visual Systems (EVS), which integrates "capture, recording, distribution, and display."
Business Model
The company employs a vertically integrated model that completes product planning, development, and production within its own group, positioning high quality and high reliability as the source of its competitive advantage. It has established direct sales subsidiaries in Europe, North America, China, India, and the Middle East, building a direct sales system that eliminates reliance on distributors. By providing long-term stable supply and long-term maintenance systems for regulated industries such as healthcare and air traffic control, the company raises customers' switching costs and secures continuous revenue. Shareholder returns target 70%+α of consolidated net income attributable to owners of parent, with a dividend floor set at ¥105.00 per share.
Company Strengths
Sales in the healthcare market were ¥36,578 million (up 7.2% year on year), accounting for 45.0% of total company sales, making it the largest market. The company offers EVS solutions that integrate "capture, record, distribute, and display" functions, ranging from diagnostic monitors to surgical field cameras and video recording/distribution systems, and sales are on a recovery trend in Europe, North America, China, the Middle East, and India.
The company maintains the No. 1 global market share in air traffic control applications within the V&S market. It provides dedicated products with high visibility, dust/water resistance, and long-term stable operation, along with a long-term maintenance system, giving it a foundation to capture demand from new airport construction in emerging markets such as India and the Middle East, as well as demand for upgrades to high-resolution monitors.
The company maintains a 100% in-house production system centered on its main factory at its headquarters in Hakusan City, Ishikawa Prefecture, with a new technology building completed in April 2025 (capital investment of ¥2,971 million during the fiscal year). It has development sites in Japan, Germany, the United States, and China, with R&D expenses of ¥6,862 million (up ¥144 million year on year). This enables high-mix, low-volume production, flexible custom support, and long-term stable supply, forming a barrier to entry in specialized markets.
ENVALITH's Perspective
Performance Trend
Revenue peaked at ¥86,789 million in FY2022 (ending March 2022), then declined and has remained flat in the low-¥80,000 million range since FY2023 (ending March 2023), reaching ¥81,308 million in FY2026 (ending March 2026), up 1.0% year on year. Operating profit fell for four consecutive periods, from ¥11,299 million in FY2022 (ending March 2022) to ¥2,365 million in FY2026 (ending March 2026), with the operating profit margin declining to 2.9%. As an external factor, the prolonged downturn in the European economy suppressed sales in the B&P and creative work markets, while inventory valuation losses and increased SG&A expenses pressured profits. On the other hand, net income rose sharply to ¥7,323 million (up 76.5% year on year), driven by a gain of ¥7,999 million on the sale of investment securities. Comprehensive income also improved significantly to ¥20,568 million from ¥-866 million in the prior period, mainly due to an increase in valuation difference on available-for-sale securities (¥10,573 million).
Growth Strategy
Recovery in earnings driven by deepening V&S engagement, multi-regional healthcare expansion, EVS growth, and expansion into India and the Middle East
Orders in air traffic control, marine, surveillance, defense, and other segments are accumulating, and the company plans V&S revenue of ¥15,200 million (up 21.1% year on year) for FY2027 (ending March 2027). Key growth drivers are expanded air traffic control orders in North America and increased sales of graphics boards for defense applications. This business is positioned as the driving force behind the recovery in earnings for the group as a whole.
The company is strengthening its sales structure primarily in Europe, North America, China, India, and the Middle East, and plans healthcare revenue of ¥37,300 million (up 2.0% year on year) for FY2027 (ending March 2027). In Japan, cautious demand trends are expected due to the deteriorating management environment at medical institutions, while overseas, sales appear to have bottomed out, and the company aims to transition to a recovery trajectory.
The company is rolling out systems solutions as EIZO Visual Systems (EVS), primarily for surveillance applications, in response to demand for the maintenance and management of social infrastructure. It is accelerating the shift from standalone hardware sales to a systems-proposal-based business model to increase added value and secure customer retention. This is a priority initiative under the 8th Medium-Term Business Plan (final year FY2026).
The company plans revenue of ¥2,850 million (up 3.7% year on year) for FY2027 (ending March 2027) from other regions, positioning India and the Middle East as growth markets. It is expanding local sales activities through EIZO Middle East Ltd. (Saudi Arabia) and EIZO Private Limited (India), and is promoting the acquisition of new business in the healthcare and V&S markets.
As part of restructuring functions and roles within the European group, the company has restructured its sales organization (optimizing headcount) and closed some development and production facilities. In FY2026 (ending March 2026), it recorded business structure improvement expenses of ¥441 million and fixed asset impairment of ¥497 million. In FY2027 (ending March 2027), the company plans to control fixed costs through rationalization effects and operational efficiency improvements, keeping SG&A expenses within ¥24,400 million (up 3.7% year on year).
The company continues to sell policy-holding shares and shares held for pure investment purposes, and plans a gain on sale of investment securities of approximately ¥4,400 million in FY2027 (ending March 2027). It aims for a total shareholder return ratio of 70% plus alpha, maintaining 13 consecutive years of dividend increases (forecast of ¥115 per share for FY2027 (ending March 2027)). In May 2026, the company resolved to conduct a share buyback (up to 1,500,000 shares, ¥4,000 million maximum) to improve capital efficiency.
Last updated: July 19, 2026